Canland Health Announces Closing of Non-Brokered Private Placement

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

VANCOUVER, BC / ACCESSWIRE / October 22, 2019 / Canland Health Corp. (the “Company”) today announced that it has closed the previously announced non-brokered private placement (the “Private Placement”) raising gross proceeds of $365,000 from the issuance and sale of 3,650,000 common shares (“Common Shares”) at a price of $0.10 per Common Share. No new insiders were created as a result of this Private Placement.

The Private Placement was previously announced on October 17, 2019.

The Common Shares issued under the Private Placement will be subject to a four month and one day resale restriction. The Company intends to use the net proceeds of the Private Placement for evaluating new opportunities as part of its business model and for working capital purposes.

For further information regarding this news release contact:

C.K. Cheung, CEO
Tel: 416 904 1478

On behalf of the Board of Directors

CANLAND HEALTH CORP.

THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO SELL ANY OF THE SECURITIES DESCRIBED HEREIN IN THE UNITED STATES. THESE SECURITIES HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE UNITED STATED SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.

SOURCE: Canland Health Corp.

View source version on accesswire.com:
https://www.accesswire.com/563796/Canland-Health-Announces-Closing-of-Non-Brokered-Private-Placement

Staff

Recent Posts

Rapid Dose Announces Completion of Share Issuance in Debt Settlement with Creditors

Burlington, Ontario--(Newsfile Corp. - June 2, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT"…

1 hour ago

Evosep unveils new instrumentation and partnership at ASMS 2025

Evosep Eno The new Evosep Eno from Evosep will set the stage for next generation…

2 hours ago

Solera Health Unveils Enhanced AI Governance Framework for Responsible and Transparent Use of Artificial Intelligence in Digital Health

Framework Sets an Industry Benchmark for Client Trust and Ethical AI Use to Ensure Patient…

2 hours ago